ECAT BlackRock ESG Capital Allocation Term Trust Insider Trading

Saba Capital Management (10% Owner) sold 64,727 shares of ECAT at $15.64 on 2026-07-15, reducing stake to 17,066,950 shares.

Saba Capital Management sold 64,727 shares for $1,012,330.28 as part of a series of five sales at ECAT spanning 2026-07-01 through 2026-07-15. The transaction reduced the firm's holdings by -0.4% versus pre-transaction levels, maintaining a substantial 17.07M share position. At the transaction price of $15.64, the stock was trading 9.1% below its 52-week high of $17.14, and the current price of $15.58 sits near the execution level. The outcome timing for these recent consecutive sales cannot yet be assessed (90-day and 30-day returns are not measurable for trades executed within the past week).

Rieder purchased 35,734 shares of ECAT at $15.86 on 2026-07-13, raising holdings 33.8% to 141,464 shares.

Rieder Richard M acquired 35,734 shares at $15.86, representing a substantial 33.8% increase in his ECAT position and a total commitment of $566,648.33. This is his second open-market purchase of the closed-end fund, following a prior buy on 2024-01-05 where his 90-day return was +3.9%. His cross-ticker track record shows 1 prior buy with an average 90-day return of +3.9% and a 100.00% win rate, indicating a pattern of well-timed purchases. The current price of $15.65 sits 8.7% below the 52-week high of $17.14, and the fund has gained 7.9% over the past 90 days, providing context for the timing of this substantial addition to his holdings.

Saba Capital sells 161,408 shares of ECAT for $2,566,293.50 across 2 transactions; recent pattern of consecutive daily sales

Saba Capital Management, LP executed 2 separate sales totaling 161,408 shares for $2,566,293.50 on 2026-07-13 and 2026-07-14 at a blended average price of $15.90, reducing holdings from 17,293,085 shares to 17,131,677 shares (a -0.9% reduction). This sale occurs within a broader pattern: SAME-TICKER HISTORY shows 5 consecutive prior sales at ECAT spanning 2026-06-25 through 2026-07-01, suggesting sustained discretionary selling activity. The current price of $15.65 is -8.7% from the 52-week high of $17.14, and 30-day performance is +1.5%, positioning these sales near but not at recent peaks. Cross-ticker track record shows 10 prior buys and 10 prior sells with no measurable timing outcomes yet available for the recent ECAT transactions, limiting inferential power about pattern quality at this specific ticker.

Saba Capital (10% owner) sold 132,402 shares of ECAT at $15.71–$15.82 for $2.1M; maintains 17.29M share position

Saba Capital Management executed two separate sales totaling 132,402 shares for $2,085,148.66 at a blended average price of $15.75, reducing its stake by 0.8% to 17,293,085 shares. The transaction occurred at prices modestly below the current price of $15.84, and within the 52-week range of $13.36–$17.14. This sale follows a pattern of five consecutive sell transactions by the same insider at ECAT over the preceding two weeks (July 1, June 30, June 29, June 26, and June 25), suggesting sustained disposition activity rather than an isolated event. The cross-ticker track record shows balanced activity (10 prior buys, 10 prior sells), with no measurable 90-day return data yet available on the same-ticker prior sells, limiting inference about execution timing at this specific security.

Saba Capital (10% owner) sells 223,991 shares in ECAT for $3,526,193.06; reduces stake to 17.52M shares

Saba Capital Management executed two separate sales totaling 223,991 shares for $3,526,193.06 at an average price of $15.74 per share on June 30 and July 1, 2026. The sale reduced the firm's holdings by 1.3% from 17.74M shares to 17.52M shares, a modest reduction for a 10% owner. At the current price of $15.80, the transaction was executed near recent market levels; the stock is currently -7.8% from its 52-week high of $17.14. Notably, this sale follows a pattern of five consecutive prior sales at ECAT on June 15, 16, 23, 24, and 25, 2026—all within the prior two weeks—suggesting a sustained phase of position reduction rather than an isolated tactical move.

Saba Capital Management sells 188,125 shares of ECAT for $2,910,809.06 across two trades (June 26-29, 2026)

Saba Capital Management, LP (10% Owner) executed two separate sales totaling 188,125 shares for $2,910,809.06 at a blended average price of $15.47, reducing holdings from 17.93M to 17.74M shares (-1.0%). The current price of $15.72 is 8.3% below the 52-week high of $17.14, and the stock has gained 13.2% over 90 days. This filing occurs within a series of five prior sales at ECAT spanning June 15-25, 2026, indicating sustained selling activity by the 10% holder during a period of upward price momentum. The lack of measurable 90-day outcomes on the recent prior trades prevents assessment of execution timing within this cluster.

Saba Capital Management sold 111,432 shares of ECAT at $15.40; extends 5-trade sell sequence in four days

Saba Capital Management, LP (10% owner) sold 111,432 shares on 2026-06-25 at $15.40, reducing its position from 18,042,176 shares to 17,930,744 shares (a -0.6% reduction). This sale is the fifth consecutive sell transaction at ECAT within a narrow four-day window: sales occurred on 2026-06-25, 2026-06-16, 2026-06-15, 2026-06-12, and 2026-06-11. The current market price of $15.39 is -10.2% from the 52-week high of $17.14, and the stock has declined -0.7% over 30 days while gaining +14.8% over 90 days. The rapid, repetitive sell pattern at this ticker lacks measurable 30- and 90-day outcome data for any of the five trades, so historical timing assessment is not yet possible. Across Saba's broader open-market history (cross-ticker), the track record shows 12 prior buys versus 8 prior sells, providing limited context for evaluating whether this concentrated exit sequence reflects opportunistic liquidation or a shift in portfolio positioning.

10% owner Saba Capital sold 203,261 shares of ECAT at $15.30 avg over 2 days for $3.1M; current price $15.40

Saba Capital Management executed 2 separate sales totaling 203,261 shares for $3,110,694.05 at a blended average price of $15.30 on 2026-06-23 and 2026-06-24, reducing its stake from 18,245,437 shares to 18,042,176 shares (-1.1%). The sales occurred at prices slightly below the current market price of $15.40, and follow a pattern of 5 consecutive sell transactions at this ticker between 2026-06-10 and 2026-06-16. Within the 52-week context, the stock has risen 14.9% over 90 days but currently trades 10.2% below its 52-week high of $17.14, situating these sales within a period of relative strength. The sustained sequence of sales by a 10% owner warrants tracking whether this reflects ongoing portfolio adjustment or a broader shift in conviction at this position.

Saba Capital sells 118,920 ECAT shares in 2 separate transactions (59,449 @ $15.49; 59,471 @ $15.45) for $1,839,691.96; stock +1.8% (30d), +11.1% (90d).

Saba Capital Management, LP sold 118,920 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) in two separate transactions on 2026-06-15 and 2026-06-16 at an average price of $15.47, reducing holdings by -0.6% to 18,360,395 shares. The sales come as ECAT has climbed +1.8% over 30 days and +11.1% over 90 days from the transaction period, with current price at $15.36 still -10.4% below the 52-week high of $17.14. Notably, Saba has executed five consecutive sells at ECAT (2026-06-02, 2026-06-04, 2026-06-05, 2026-06-09, 2026-06-10), with outcomes on these earlier transactions not yet measurable at the 30-day and 90-day horizons, suggesting an ongoing liquidity or repositioning activity. Cross-ticker track record shows 14 prior buys versus 6 prior sells, but same-ticker history at ECAT presents a series of recent dispositions without yet-established timing outcomes.

Saba Capital sells 207,617 shares of ECAT at $15.20 avg for $3,155,825.41 across two transactions; fifth consecutive sale in 6 days.

Saba Capital Management, LP conducted 2 separate sales totaling 207,617 shares for $3,155,825.41 on 2026-06-11 and 2026-06-12, reducing holdings by -1.1% versus pre-transaction levels. The stock trades at $15.42, near the blended transaction price of $15.20. This transaction is the fifth sell by this insider at ECAT in a 6-day window (2026-06-02 through 2026-06-12), representing an unusually concentrated pattern of exits from the same security. As a 10% owner, the insider retains 18,479,315 shares, maintaining a substantial stake despite the recent sales activity.